Core Med Tech Development ApS: Financial statements 2022
CVR: 37703788
Source: annual report 2022, Danish Business Authority
01/05/2021 – 30/04/2022
Core Med Tech Development ApS (CVR 37703788) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,492 and a net result of DKK -4,340,711 compared with DKK 35,952,930 the year before. Equity in the 2022 report amounted to DKK 16,738,045. The solvency ratio was 98.1%.
- Gross Profit
- DKK -13,492
- Profit/Loss
- DKK -4,340,711
- Equity
- DKK 16,738,045
- Total Assets
- DKK 17,056,585
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -13 t. | -4.3 mio. | 16.7 mio. | - |
| 2021 | - | -1.8 mio. | 36 mio. | 27.1 mio. | - |
| 2020 | - | -52 t. | 1.9 mio. | 16.1 mio. | - |
| 2019 | - | -8 t. | 7.2 mio. | 15.2 mio. | - |
| 2018 | - | -9 t. | 3.5 mio. | 8.3 mio. | - |
Keep an eye on Core Med Tech Development ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Core Med Tech Development ApS
Core Med Tech Development ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Christian Schärfe Baltzer-Thomsen and Steffen Vogel. The company is owned by SASSER G HOLDING ApS and Baltho Holding ApS. In 2025, the company reported a gross profit of DKK -220,933 and a net result of DKK -99,037 compared with DKK 1,645,725 the year before. Equity in the 2025 report amounted to DKK 15,007,343.